News
The FDA is requiring label updates for all GLP-1 receptor agonist medications to warn of a potential increased risk of a rare, serious eye condition linked to risk factors that include sleep apnea.
Read More
A new bidirectional AI scheduling tool aims to capture late-night patient demand, verify insurance automatically, and eliminate front-desk phone bottlenecks for sleep centers.
Read More
Findings suggest third-trimester screening for the sleep disorder may help identify those at elevated risk and support earlier intervention.
Read More
COMISA SHCOMISA! A call to cogitate about the newest jargon on the block.
Read More
The designation expedites the development of a dual orexin receptor antagonist for children and adolescents, a demographic currently lacking FDA-approved pharmacological treatments for insomnia.
Read More
A cardiac monitoring company extends its reach into sleep medicine, adding software that evaluates sleep-disordered breathing alongside cardiac arrhythmias—to support concurrent evaluation of two clinically associated co...
Read More
The Centers for Medicare & Medicaid Services (CMS) has finalized the calendar year 2027 Medicare Physician Fee Schedule values for the new unattended sleep testing Current Procedural Terminology (CPT) code family, wh...
Read More
It chooses to fast-track services that are widely considered in the medical community to be safe and effective, according to a release.
Read More
A EUR 288 million provision has been recorded to resolve criminal and civil investigations related to its sleep therapy device recall, with payment expected in 2027.
Read More
Third-quarter financial results at the biopharma company highlight increased prescription volume for an excessive daytime sleepiness treatment and upcoming milestones for investigational narcolepsy and shift work disorde...
Read More